Allegion
ALLE
147.91
-7.29
-4.70%
Allegion
US · ALLE
#1239 by market cap
Listed 1970
147.91
-7.29
-4.70%
Live - 5344 symbols - heartbeat 129s ago
· 2026-10-08 05:16
Pre-market
147.77
-0.09%
After-hours
147.91
0.00%
- Market cap
- 12.58B
- P/E (TTM)i
- 19.41
- P/Bi
- 5.94
- EPSi
- 7.44
- Div yieldi
- 1.43%
- 52W posi
- 42%
Reader sentiment
Are you bullish or bearish on ALLE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.46, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.82% YoY
Margins
- Gross margin
- 45.20%
- Operating margin
- 21.13%
- Net margin
- 15.83%
Key ratios & quality
- Enterprise valuei
- 14.20B
- PEG ratioi
- 1.61
- Altman Z-Scorei
- 4.46
PEG uses trailing P/E against the 3-year net income growth rate (12.02%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.73B | 2.85B | 2.72B | 2.87B | 3.27B | 3.65B | 3.77B | 4.07B |
| Gross profit | 1.17B | 1.25B | 1.18B | 1.20B | 1.32B | 1.58B | 1.67B | 1.84B |
| Selling & admin expenses | 647.50M | 681.30M | 635.70M | 674.70M | 736.00M | 865.60M | 887.80M | 978.80M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 525.80M | 571.00M | 543.10M | 530.20M | 586.40M | 715.90M | 780.70M | 859.50M |
| Pretax profit | 475.20M | 475.20M | 365.40M | 524.00M | 514.50M | 617.20M | 698.80M | 768.40M |
| Tax | 39.80M | 73.10M | 50.90M | 40.70M | 56.20M | 76.60M | 101.30M | 124.60M |
| Net profit | 435.40M | 402.10M | 314.50M | 483.30M | 458.30M | 540.60M | 597.50M | 643.80M |
| Basic EPS | 5 | 4 | 3 | 5 | 5 | 6 | 7 | 7 |
| Diluted EPS | 4.54 | 4.26 | 3.39 | 5.34 | 5.19 | 6.12 | 6.82 | 7.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 941.90M | 1.02B | 1.07B | 1.03B | 1.03B | 1.15B |
| Gross profit | 422.50M | 466.50M | 489.80M | 459.50M | 454.50M | 517.50M |
| Selling & admin expenses | 226.10M | 246.80M | 256.00M | 249.90M | 259.20M | 262.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 196.40M | 219.70M | 233.80M | 209.60M | 195.30M | 254.70M |
| Pretax profit | 175.20M | 200.40M | 208.90M | 183.90M | 171.50M | 227.90M |
| Tax | 27.00M | 40.70M | 20.50M | 36.40M | 33.40M | 43.30M |
| Net profit | 148.20M | 159.70M | 188.40M | 147.50M | 138.10M | 184.60M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.71 | 1.85 | 2.18 | 1.70 | 1.59 | 2.15 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 931.60M | 1.00B | 1.15B | 1.12B | 1.21B | 1.36B | 1.42B | 1.39B |
| Cash & ST investments | 283.80M | 355.30M | 480.40M | 397.90M | 288.00M | 468.10M | 503.80M | 356.20M |
| Inventory | 280.30M | 269.90M | 283.10M | 380.40M | 479.00M | 438.50M | 423.00M | 519.00M |
| Total assets | 2.81B | 2.97B | 3.07B | 3.05B | 3.99B | 4.31B | 4.49B | 5.22B |
| Total current liabilities | 520.80M | 507.00M | 521.50M | 601.20M | 703.60M | 1.08B | 696.90M | 755.40M |
| Short-term debt | 35.30M | 100.00K | 200.00K | 12.60M | 12.60M | 412.60M | 21.90M | 200.00K |
| Long-term debt | 1.41B | 1.43B | 1.43B | 1.43B | 2.08B | 1.60B | 1.98B | 1.98B |
| Total liabilities | 2,156,200,000.00 | 2,206,800,000.00 | 2,236,800,000.00 | 2,288,600,000.00 | 3,046,700,000.00 | 2,993,200,000.00 | 2,987,100,000.00 | 3,156,100,000.00 |
| Total equity | 654.00M | 760.40M | 832.60M | 762.40M | 944.50M | 1.32B | 1.50B | 2.07B |
| Retained earnings | 873.60M | 975.10M | 985.60M | 952.60M | 1.21B | 1.58B | 1.83B | 2.24B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.46B | 1.68B | 1.40B | 1.39B | 1.42B | 1.50B |
| Cash & ST investments | 494.50M | 656.80M | 302.70M | 356.20M | 308.90M | 320.60M |
| Inventory | 443.60M | 479.50M | 524.90M | 519.00M | 537.20M | 541.90M |
| Total assets | 4.56B | 4.91B | 5.23B | 5.22B | 5.31B | 5.36B |
| Total current liabilities | 672.40M | 728.50M | 792.60M | 755.40M | 745.80M | 777.30M |
| Short-term debt | 25.00M | 24.90M | 28.20M | 200.00K | 300.00K | 200.00K |
| Long-term debt | 1.97B | 2.04B | 2.06B | 1.98B | 2.03B | 2.03B |
| Total liabilities | 2,957,200,000.00 | 3,128,300,000.00 | 3,278,700,000.00 | 3,156,100,000.00 | 3,210,900,000.00 | 3,242,200,000.00 |
| Total equity | 1.61B | 1.79B | 1.95B | 2.07B | 2.10B | 2.12B |
| Retained earnings | 1.90B | 1.99B | 2.13B | 2.24B | 2.33B | 2.35B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 457.80M | 488.20M | 490.30M | 488.60M | 459.50M | 600.60M | 675.00M | 783.80M |
| Depreciation & amortization | 86.20M | 83.00M | 81.00M | 83.10M | 97.90M | 111.60M | 119.00M | 133.20M |
| Free cash flow | 408.70M | 422.60M | 443.20M | 443.20M | 395.50M | 516.40M | 582.90M | 685.70M |
| Dividends paid | -79.40M | -100.60M | -117.30M | -129.00M | -143.90M | -158.70M | -167.00M | -175.30M |
| Stock buybacks / issuance | -67.30M | -226.00M | -208.80M | -412.80M | -61.00M | -59.90M | -220.00M | -80.00M |
| Ending cash balance | 290.60M | 358.70M | 480.40M | 397.90M | 288.00M | 468.10M | 503.80M | 356.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 104.50M | 209.70M | 229.50M | 240.10M | 101.30M | 198.40M |
| Depreciation & amortization | 30.00M | 31.90M | 36.70M | 34.60M | 35.60M | 35.70M |
| Free cash flow | 83.40M | 192.00M | 209.80M | 200.50M | 80.30M | 180.50M |
| Dividends paid | -43.60M | -44.20M | -43.60M | -43.90M | -47.40M | -46.60M |
| Stock buybacks / issuance | -40.00M | -40.00M | 0 | 0 | -40.60M | -120.00M |
| Ending cash balance | 494.50M | 656.80M | 302.70M | 356.20M | 308.90M | 320.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 82.63 | 57.06 | 39.61 | 60.81 | 53.85 | 47.82 | 42.39 | 36.08 |
| ROA %i | 16.25 | 13.91 | 10.41 | 15.78 | 13.01 | 13.02 | 13.58 | 13.26 |
| ROIC %i | 24.34 | 20.91 | 16.09 | 23.72 | 20.03 | 19.34 | 19.53 | 19.03 |
| 5-year avg ROE %i | -- | 411.11 | 123.07 | 69.25 | 58.79 | 51.83 | 48.90 | 48.19 |
| EBIT margin %i | 19.37 | 18.61 | 15.31 | 20.03 | 18.04 | 19.46 | 21.23 | 21.38 |
| FCF / sales %i | 14.96 | 14.81 | 16.29 | 15.46 | 12.09 | 14.14 | 15.45 | 16.86 |
| Current ratioi | 1.79 | 1.98 | 2.20 | 1.86 | 1.73 | 1.26 | 2.04 | 1.84 |
| Quick ratioi | 1.20 | 1.38 | 1.59 | 1.18 | 0.98 | 0.82 | 1.37 | 1.09 |
| Debt / assetsi | 51.41 | 48.12 | 46.58 | 47.27 | 52.48 | 46.74 | 44.55 | 37.91 |
| LT debt / equityi | 216.51 | 188.49 | 172.34 | 188.32 | 221.06 | 121.55 | 131.78 | 95.76 |
| Interest coveragei | 9.80 | 9.49 | 8.15 | 11.44 | 7.78 | 7.63 | 7.85 | 8.61 |
| Revenue CAGR (3Y) %i | 9.72 | 8.44 | 4.14 | 1.63 | 4.66 | 10.31 | 9.57 | 7.52 |
| Net income CAGR (3Y) %i | 41.38 | 20.59 | 4.77 | 3.56 | 4.46 | 19.80 | 7.35 | 12.02 |
| FCF CAGR (3Y) %i | 22.60 | 8.05 | 14.16 | 2.74 | -2.19 | 5.23 | 9.56 | 20.13 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 42.05 | 38.99 | 36.41 | 36.08 | 34.18 | 33.73 |
| ROA %i | 14.05 | 12.92 | 12.56 | 13.26 | 12.83 | 12.82 |
| ROIC %i | 19.90 | 18.16 | 17.86 | 19.03 | 18.34 | 18.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.59 | 21.56 | 21.31 | 21.38 | 20.80 | 20.82 |
| FCF / sales %i | 16.82 | 17.60 | 17.09 | 16.86 | 16.41 | 15.65 |
| Current ratioi | 2.17 | 2.30 | 1.77 | 1.84 | 1.91 | 1.93 |
| Quick ratioi | 1.43 | 1.56 | 1.01 | 1.09 | 1.10 | 1.13 |
| Debt / assetsi | 43.75 | 42.06 | 39.95 | 37.91 | 38.23 | 37.89 |
| LT debt / equityi | 122.72 | 114.32 | 105.80 | 95.76 | 96.63 | 95.86 |
| Interest coveragei | 7.95 | 8.09 | 8.39 | 8.61 | 8.61 | 8.87 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Products is the largest reported line at 93.84% of revenue, across 2 reported segments.
- The next-largest line, Services and software, is a distant second at 6.16% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Products93.84%
Services and software6.16%
Quote time 2026-10-08 05:16:36 · For reference only, not investment advice and not tailored to your situation.